Evidence map›Paper›PMID 37783733›Full record

ArticleNature communications2023

Hypersensitive MR angiography based on interlocking stratagem for diagnosis of cardiac-cerebral vascular diseases.

Peisen Zhang, Junwei Cheng, Yijie Lu, Ni Zhang, Xiaoai Wu, Hua Lin, Wei Li, Jian Wang, Mitchell A Winnik, Zhihua Gan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. [Application of nanomaterials-enhanced magnetic resonance imaging in precise diagnosis of pan-vascular diseases].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  2. Article
  3. Article
  4. [Imaging Diagnosis of Ischemic Stroke Through Multiparametric Magnetic Resonance Angiography Enhanced by NaGdFSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Peisen Zhang *College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.ORCID http://orcid.org/0000-0003-0569-0576
Junwei Cheng *College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Yijie Lu *Department of Chemistry, University of Toronto, Toronto, ON, M5S 3H6, Canada.
Ni ZhangDepartment of Psychiatry, and Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xiaoai WuDepartment of Psychiatry, and Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Hua LinDepartment of Psychiatry, and Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
Wei LiDepartment of Nanomedicine & International Joint Cancer Institute, Naval Medical University, Shanghai, 200433, China. liwei_dds@163.com.
Jian WangDepartment of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, China.
Mitchell A WinnikDepartment of Chemistry, University of Toronto, Toronto, ON, M5S 3H6, Canada.
Zhihua GanCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. zhgan@mail.buct.edu.cn.
Yi HouCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. houyi@iccas.ac.cn.ORCID http://orcid.org/0000-0001-7026-6929
Beijing University of Chemical Technology · CNSichuan University · CNUniversity of Toronto · CAChinese Academy of Medical Sciences & Peking Union Medical College · CNShanghai International Medical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic resonance (MR) angiography is one of the main diagnostic approaches for cardiac-cerebral vascular diseases. Nevertheless, the non-contrast-enhanced MR angiography suffers from its intrinsic problems derived from the blood flow-dependency, while the clinical Gd-chelating contrast agents are limited by their rapid vascular extravasation. Herein, we report a hypersensitive MR angiography strategy based on interlocking stratagem of zwitterionic Gd-chelate contrast agents (PAA-Gd). The longitudinal molar relaxivity of PAA-Gd was 4.6-times higher than that of individual Gd-chelates as well as appropriate blood half-life (73.8 min) and low immunogenicity, enabling sophisticated micro-vessels angiography with a resolution at the order of hundred micrometers. A series of animal models of cardiac-cerebrovascular diseases have been built for imaging studies on a 7.0 T MRI scanner, while the clinical translation potential of PAA-Gd has been evaluated on swine on a 3.0 T clinical MRI scanner. The current studies offer a promising strategy for precise diagnosis of vascular diseases.

Indexed as

Cerebrovascular DisordersContrast MediaAnimalsChelating AgentsMagnetic Resonance AngiographyMagnetic Resonance ImagingSwineChelating AgentsContrast Media

Identifiers

PMID37783733
PMCPMC10545789
OpenAlexW4387268081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.